Filing Details
- Accession Number:
- 0001225208-22-006244
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2022-04-28 21:02:09
- Reporting Period:
- 2022-04-28
- Accepted Time:
- 2022-04-28 21:02:09
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1099800 | Edwards Lifesciences Corp | EW | Orthopedic, Prosthetic & Surgical Appliances & Supplies (3842) | 364316614 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1500281 | H. Martha Marsh | One Edwards Way Irvine CA 92614 | Yes | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2022-04-28 | 28,722 | $25.99 | 55,499 | No | 4 | M | Direct | |
Common Stock | Disposition | 2022-04-28 | 28,722 | $108.09 | 26,777 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Director Stock Option (Right to Acquire) | Disposition | 2022-04-28 | 28,722 | $0.00 | 28,722 | $25.99 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
0 | 2016-11-19 | 2022-11-18 | No | 4 | M | Direct |
Footnotes
- This transaction was executed in multiple trades at prices ranging from $108.00 to $108.55. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide, upon request by the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected.